Effect of Atorvastatin on Microcirculation Evaluated by Vascular Occlusion Test with Peripheral Near-Infrared Spectroscopy

Keiichiro Kuronuma; Tsukasa Yagi; Shonosuke Sugai; Satoshi Hayashida; Kazuki Iso; Korehito Iida; Wataru Atsumi; Eizo Tachibana; Satoshi Kunimoto; Yasuyuki Suzuki; Shigemasa Tani; Naoya Matsumoto; Yasuo Okumura; Kaoru Sakatani

doi:10.1007/978-3-031-14190-4_57

Effect of Atorvastatin on Microcirculation Evaluated by Vascular Occlusion Test with Peripheral Near-Infrared Spectroscopy

Adv Exp Med Biol. 2022:1395:351-356. doi: 10.1007/978-3-031-14190-4_57.

Authors

Affiliations

¹ Department of Cardiology, Kawaguchi Municipal Medical Center, Kawaguchi, Japan.
² Department of Medicine, Division of Cardiology, Nihon University School of Medicine, Tokyo, Japan.
³ Department of Human and Engineered Environmental Studies, Universal Sport Health Science Laboratory, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.

PMID: 36527661
DOI: 10.1007/978-3-031-14190-4_57

Abstract

The vascular occlusion test (VOT) with peripheral near-infrared spectroscopy (NIRS) is a non-invasive method to evaluate peripheral microcirculation. Statin therapy is widely used for patients with dyslipidaemia and contributes to reducing low-density lipoprotein cholesterol (LDL-C) levels and adverse cardiovascular events. However, it is not yet clear whether statin treatment improves peripheral microcirculation assessed by VOT with NIRS. In the present study, using VOT with NIRS, we evaluated the effect of statin therapy on peripheral microcirculation in patients with dyslipidaemia before and after statin therapy.

Methods: A total of six consecutive patients with dyslipidaemia who had not received statin therapy (6 males, mean age 71.8 ± 7.4 years) were enrolled. All patients were administered atorvastatin and their peripheral microcirculation assessed using VOT with NIRS (NIRO-200NX, Hamamatsu Photonics K.K., Japan) before and after statin therapy. The NIRS probe was attached to the right thenar eminence and brachial artery blood flow was blocked for 3 min at 50 mmHg above the resting systolic blood pressure. Maximum and minimum values of NIRS parameters after the VOT were used to determine concentration changes for total haemoglobin (ΔcHb), oxyhaemoglobin (ΔO₂Hb), deoxyhaemoglobin (ΔHHb), and tissue oxygenation index (ΔTOI).

Results: During the follow-up period (mean 30.3 ± 6.5 days), LDL-C level decreased from 129.7 ± 26.3 to 67.5 ± 20.2 mg/dL (p-value = 0.031), ΔTOI increased from 24.0 ± 5.3 to 33.7 ± 6.3% (p-value = 0.023), and ΔO₂Hb increased from 16.4 ± 5.3 to 20.0 ± 6.6 μmol/L (p-value = 0.007). ΔcHb and ΔHHb did not change significantly.

Conclusion: ΔO₂Hb and ΔTOI were significantly increased during the follow-up period. These findings suggest that ΔO₂Hb and ΔTOI could assess the improvement of peripheral microcirculation by statin therapy. Compared to ΔTOI, ΔO₂Hb seems to be a more useful parameter to evaluate peripheral microcirculation.

Keywords: Dyslipidemia; Ischemic heart disease; NIRS; Peripheral microcirculation; Statin therapy.

MeSH terms

Aged
Atorvastatin / pharmacology
Atorvastatin / therapeutic use
Cholesterol, LDL
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / pharmacology
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
Male
Microcirculation
Middle Aged
Oxygen Consumption
Spectroscopy, Near-Infrared
Vascular Diseases*

Substances

Atorvastatin
Cholesterol, LDL
Hydroxymethylglutaryl-CoA Reductase Inhibitors